Home > Insider Trading > Filing (0001225208-10-025620)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099800	Edwards Lifesciences Corp	EW	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	364316614

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1440664	D Carlyn Solomon	One Edwards Way Irvine CA 92614	Cvp, Critical Care & Vascular	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-11-24	22,000	$24.42	58,386	No	4	M	Direct
Common Stock	Acquisiton	2010-11-24	10,200	$25.81	68,586	No	4	M	Direct
Common Stock	Acquisiton	2010-11-24	8,250	$21.96	76,836	No	4	M	Direct
Common Stock	Disposition	2010-11-24	40,450	$65.90	36,386	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2010-11-24	10,200	$0.00	10,200	$25.81
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2010-11-24	22,000	$0.00	22,000	$24.42
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2010-11-24	8,250	$0.00	8,250	$21.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,400	2008-02-15	2014-02-14	No	4	M	Direct
22,000	2008-05-10	2014-05-09	No	4	M	Direct
0	2007-05-11	2013-05-10	No	4	M	Direct

Footnotes

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
This transaction was executed in multiple trades at prices ranging from $65.80 to $66.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.